A new cyclohexenone derivative from phomopsis sp. XM-01

Area of Science:

• Natural Product Chemistry
• Microbiology
• Medicinal Chemistry

Background:

• Fungi are a prolific source of structurally diverse natural products.
• Phomopsis species are known to produce bioactive secondary metabolites.
• Exploring microbial metabolites is crucial for discovering new therapeutic agents.

Purpose of the Study:

• To isolate and characterize novel and known compounds from Phomopsis sp. XM-01.
• To evaluate the antimicrobial potential of the isolated compounds.
• To identify new lead compounds for drug development.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation of the new compound (1) via spectroscopic analysis (NMR, MS) and electronic circular dichroism (ECD) calculation.
• In vitro antimicrobial activity testing against Candida albicans and Staphylococcus aureus using broth microdilution assays to determine minimum inhibitory concentrations (MICs).

Main Results:

• A new cyclohexenone derivative, phomopine (1), was isolated and characterized.
• Five known compounds (2-6) were also identified from the fungal extract.
• Phomopine (1) and compound 2 demonstrated significant antimicrobial activity against Candida albicans and Staphylococcus aureus, with MICs of 64 μg/mL and 16 μg/mL, respectively.

Conclusions:

• Phomopine is a newly identified natural product with potential antimicrobial properties.
• The isolated compounds, particularly phomopine, warrant further investigation as potential antimicrobial drug leads.
• Phomopsis sp. XM-01 is a valuable source for discovering bioactive natural products.